Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The buccal administration of a NanoCelle Cannabidiol formulation to healthy volunteers: a pharmacokinetic, safety and tolerability exploratory pilot study

Trial Profile

The buccal administration of a NanoCelle Cannabidiol formulation to healthy volunteers: a pharmacokinetic, safety and tolerability exploratory pilot study

Not yet recruiting
Phase of Trial: Phase 0

Latest Information Update: 19 Nov 2018

At a glance

  • Drugs Cannabidiol (Primary) ; Propylene glycol
  • Indications Pain
  • Focus Adverse reactions
  • Sponsors Medlab
  • Most Recent Events

    • 08 Nov 2018 Planned initiation date changed from 15 Nov 2018 to 10 Jan 2019.
    • 23 Aug 2018 Planned initiation date changed from 1 Feb 2018 to 15 Nov 2018.
    • 27 Oct 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top